Study Status: Suspended
Recruit Status: Suspended
Study Type: Interventional
Official Title: A Phase 2 Study of Vorinostat (NSC 701852) in Metastatic Uveal Melanoma
Brief Summary: This phase II trial studies how well vorinostat works in treating patients with melanoma of the eye that has spread to other parts of the body. Vorinostat may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.